Cystic fibrosis newborn screening: using experience to optimize the screening algorithm

By Hale Jaime   Parad Richard   Dorkin Henry   Gerstle Robert   Lapey Allen   O’Sullivan Brian   Spencer Terry   Yee William   Comeau Anne  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 2, 2010-10 ,pp. : 255-261

Springer Publishing Company

Access to resources Recommend Favorite

The influence of sex, gestational age, birth weight, blood transfusion, and timing of the heel prick on the pancreatitis-associated protein concentration in newborn screening for cystic fibrosis

By Vernooij-van Langen Annette   Loeber J.   Elvers Bert   Triepels Ralf   Roefs Jos   Gille Johan   Reijntjens Sandra   Dompeling Edward   Dankert-Roelse Jeannette  

Journal of Inherited Metabolic Disease, Vol. 36, Iss. 1, 2013-01 ,pp. : 147-154

Springer Publishing Company

Access to resources Recommend Favorite

Neonatal screening for cystic fibrosis: France rises to the challenge

By Farriaux J. P.   Vidailhet M.   Briard M. L.   Belot V.   Dhondt J. L.  

Journal of Inherited Metabolic Disease, Vol. 26, Iss. 8, 2003-01 ,pp. : 729-744

Springer Publishing Company

Access to resources Recommend Favorite

Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population

By Sommerburg Olaf   Lindner Martin   Muckenthaler Martina   Kohlmueller Dirk   Leible Svenja   Feneberg Reinhard   Kulozik Andreas   Mall Marcus   Hoffmann Georg  

Journal of Inherited Metabolic Disease, Vol. 33, Iss. 2, 2010-10 ,pp. : 263-271

Springer Publishing Company

Access to resources Recommend Favorite

Compliance with science: consent or coercion in newborn screening

By Pollitt Rodney  

European Journal of Pediatrics, Vol. 163, Iss. 12, 2004-12 ,pp. : 757-758

Springer Publishing Company

Access to resources Recommend Favorite